We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HBI
13251
DELISTED
Hanesbrands
HBI
-544,236
Closed -$6.76M
HCSG icon
13252
PUT
Healthcare Services Group
HCSG
$1.48B
-59,300
Closed -$1.1M
HEFA icon
13253
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.79B
-50,309
Closed -$1.71M
HEI.A icon
13254
CALL
HEICO Corp Class A
HEI.A
$38.4B
-3,100
Closed -$393K
HEI.A icon
13255
PUT
HEICO Corp Class A
HEI.A
$38.4B
-1,600
Closed -$203K
HEPA
13256
DELISTED
Hepion Pharmaceuticals
HEPA
-12
Closed -$9.99K
HERO icon
13257
CALL
Global X Video Games & Esports ETF
HERO
$69.1M
-13,200
Closed -$331K
HFGO icon
13258
Hartford Large Cap Growth ETF
HFGO
$210M
-28,274
Closed -$461K
HFXI icon
13259
NYLI FTSE International Equity Currency Neutral ETF
HFXI
$2.12B
-61,963
Closed -$1.46M
HGTY icon
13260
CALL
Hagerty
HGTY
$1.32B
-11,300
Closed -$122K
HI
13261
DELISTED
Hillenbrand
HI
-5,597
Closed -$234K
HIBL icon
13262
PUT
Direxion Daily S&P 500 High Beta Bull 3X ETF
HIBL
$94.2M
-5,100
Closed -$314K
HISF icon
13263
First Trust Exchange-Traded Fund IV First Trust High Income Strategic Focus ETF
HISF
$99M
-13,255
Closed -$638K
HIVE
13264
HIVE Digital Technologies
HIVE
$736M
-315,470
Closed -$1.83M
HLAL icon
13265
Wahed FTSE USA Shariah ETF
HLAL
$960M
-8,836
Closed -$368K
HLIO icon
13266
CALL
Helios Technologies
HLIO
$2.69B
-2,800
Closed -$225K
HLIO icon
13267
Helios Technologies
HLIO
$2.69B
-53,054
Closed -$4.26M
HLIO icon
13268
PUT
Helios Technologies
HLIO
$2.69B
-5,600
Closed -$449K
HLMN icon
13269
PUT
Hillman Solutions
HLMN
$1.69B
-12,400
Closed -$147K
HLNE icon
13270
CALL
Hamilton Lane
HLNE
$5.74B
-3,200
Closed -$247K
HLX icon
13271
PUT
Helix Energy Solutions
HLX
$1.54B
-13,300
Closed -$64K
HNDL icon
13272
Strategy Shares Nasdaq 7HANDL Index ETF
HNDL
$638M
-11,925
Closed -$263K
RKTO
13273
Rocket One Inc
RKTO
$19M
-435
Closed -$7K
HOUR icon
13274
Hour Loop
HOUR
$68.3M
-10,276
Closed -$31K
HOWL icon
13275
Werewolf Therapeutics
HOWL
$19.7M
-20,144
Closed -$89K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.